MarketInOut Stock Screener Log In | Sign Up

SOPHiA GENETICS S.A.

NASDAQ • Healthcare • Health Information Services • Quote as of 10/30/2026
SOPHiA GENETICS S.A. stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
ExchangeNASDAQ
Market Capitalization649.53 mln
Float61.78 mln
Earnings Date11/03/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.98
Likely reliable

Relative Strength

94 / 100
Top performer

Debt / Equity

0.74
Moderate leverage

Pre-Tax Margin

-93%
Severely loss-making

ROE

-129
Deeply negative

Business Description

Founded in 2011 and headquartered in Rolle, Switzerland, SOPHiA GENETICS helps medical institutions and drug developers make better sense of complex patient data. The company's core offering is a web-based platform that processes and interprets information from multiple diagnostic sources, turning raw data into actionable clinical insights. Its tools are used by hospitals, laboratories, and life sciences organizations across Europe, North America, Latin America, and the Asia-Pacific region.

Key Fundamentals

EPS-1.16
ROE-129
RPS1.24
ROIC-87.80
ROA-47.03
Interest Cover-11.06
EBITDA, mln-63.16
EV / EBITDA-8.41
EV / EBIT-7.21
Revenue, mln86.17
EV / Revenue6.16

Quote Details

Last 7.63
Change -0.34 (-4.27%)
Open 7.95
Volume 378,981
Turnover 2,891,625
Average Volume 566,568

Financial Ratios

Pre-Tax Profit Margin-93
Leverage Ratio2.39
Current Ratio2.69
Price / Book7.69
Price / Tangible Book13.71
Debt / Equity0.74
Price / Sales6.11

Financial Strength

Altman Z-Score-0.9
Piotroski F-Score 3 / 9
Beneish M-Score-2.98
Short Ratio1.35
Short % of Float1.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.81% 86 / 100   
1 Month -4.98% 39 / 100   
2 Months 35.04% 96 / 100   
6 Months 43.42% 95 / 100   
1 Year 68.06% 95 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog